Syntax Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,343
Closed -$42K 232
2022
Q3
$42K Sell
17,343
-475
-3% -$1.58K 0.04% 210
2022
Q2
$40K Buy
+17,818
New +$66.4K 0.03% 216

Other funds holding DBD

Syntax Advisors's DBD Position: Q4 2022 in Review

Syntax Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 17,343 shares — an estimated $42K sold.

Syntax Advisors first reported a position in DBD in Q2 2022 and held it in 2 quarters. The position peaked at $42K in Q3 2022. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Syntax Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Syntax Advisors sold 17,343 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $42K.
  • Syntax Advisors first reported a position in Diebold Nixdorf Incorporated in Q2 2022 and held it in 2 quarters.
  • Syntax Advisors's Diebold Nixdorf Incorporated position peaked at $42K in Q3 2022.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Syntax Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.